Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma

Endocrine Journal

Volumn 61, Issue 8, 2014, Pages 745-750

  Ito, Yasuhiro ^a   Miyauchi, Akira ^a   Kihara, Minoru ^a   Kobayashi, Kaoru ^a   Miya, Akihiro ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Clinical node metastasis; Extrathyroid extension; Papillary thyroid carcinoma; Prognostic factor

Indexed keywords

ADULT; AGE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; LIFE EXPECTANCY; LYMPH NODE METASTASIS; MACROSCOPIC EXTRATHYROID EXTENSION; MAJOR CLINICAL STUDY; MALE; MINIMAL EXTRATHYROID EXTENSION; PREOPERATIVE EVALUATION; REVIEW; RISK FACTOR; THYROID CARCINOMA; TUMOR VOLUME; CARCINOMA; LYMPH NODE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; THYROID NEOPLASMS; TUMOR INVASION;

CARCINOMA; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 84906834223     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0138     Document Type: Review

References (37)

1. Cady B, Rosai R (1988) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
2. Hay ID, Bergstrahl EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1058.
3. Sobin LH, Wittekind CH eds. (2009) UICC: TNM classification of malignant tumors, 7th ed. New York: Wiley-Liss.
4. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, et al. (2006) Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today 36: 12-18.
5. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, et al. (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30: 780-786.
6. Moon HJ, Kim EK, Chung WY, Yoon JH, Kwak JY (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18: 1916-1923.
7. Nixon IJ, Ganly I, Patel S, Frank L, Palmer BA, et al. (2011) The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery 150: 1242-1249.
8. Hotomi M, Sugitani I, Toda K, Kawabata K, Fujimoto Y (2012) A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis. World J Surg 36: 1231-1240.
9. Shin JH, Ha TK, Park HK, Ahn MS, Kim KH, et al. (2013) Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. Int J Surg 11: 944-947.
10. Chereau N, Buffet C, Tresallet C, Tissier F, Golmard JL, et al. (2014) Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma? Ann Surg Oncol DOI 10.1245/s10434-013-3447-y
11. Hu A, Clark J, Payne RJ, Eski S, Walfish PG, et al. (2007) Extrathyroidal extension in well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 133: 644-649.
12. Rivera M, Fiho-Ricarte J, Tuttl RM, Ganly I, Shaha A, et al. (2010) Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. Thyroid 20: 1085-1093.
13. Riemann B, Kramer JA, Schmid KW, Dralle H, Dietlein M, et al. (2010) Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin 49: 79-84.
14. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135: 139-148.
15. Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, et al. (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36: 1274-1278.
16. Verburg FA, Mader U, Tanase K, Thies ED, Diessl S, et al. (2013) Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab 98: 172-180.
17. Ito Y, Miyauchi A, Kihara M, Takamura Y, Kobayashi K, et al. (2012) Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study. Endocr J 59: 399-405.
18. Ito Y, Kudo T, Takamura Y, Kobayashi K, Miya A, et al. (2011) Prognostic factors of papillary thyroid carcinoma vary according to sex and patient age. World J Surg 35: 2684-2690.
19. Ito Y, Kihara M, Takamura Y, Kobayashi K, Miya A, et al. (2012) Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years. Endocr J 59: 539-545.
20. Kim YS (2012) Patterns and predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma. Otolaryngol Head Neck Surg 147: 15-19.
21. Fukushima M, Ito Y, Hirokawa M, Miya A, Shimizu K, et al. (2010) Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary carcinoma depend on carcinoma size. World J Surg 34: 3007-3014.
22. Ito Y, Fukushima M, Kihara M, Takamura Y, Kobayashi K, et al. (2012) Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr J 59: 457-44.
23. Ito Y, Kudo T, Takamura Y, Kobayashi K, Miya A, et al. (2011) Prognostic significance of carcinoma extension from primary lesions and metastatic nodes in papillary thyroid carcinoma: appropriateness of three subdivisions of extension. Endocr J 58: 961-967.
24. Ito Y, Kihara M, Takamura Y, Kobayashi K, Miya A (2012) Prognosis and prognostic factors of patients with papillary thyroid carcinoma requiring resection of recurrent laryngeal nerve due to carcinoma extension. Endocr J 59: 247-252.
25. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, et al. (2004) Papillary microcarcinoma of the thyroid: How should it be treated? World J Surg 28: 1115-1121.
26. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, et al. (2005) Ultrasonographically and anatomopathologically detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29: 917-920.
27. Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, et al. (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31: 838-848.
28. Kim TY, Hong SJ, Kim JM, Kim WG, Gong G, et al. (2008) Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 8:296.
29. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, et al. (2010) An observation trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34: 28-35.
30. Ito Y, Fukushima M, Tomoda C, Inoue H, Kihara M, et al. (2009) Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J 56: 759-766.
31. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, et al. (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237: 399-407.
32. Wada N, Masudo K, Nakayama H, Suganuma N, Matsuzu K, et al. (2008) Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. Eur J Surg Oncol 34: 202-207.
33. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, et al. (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34: 1222-1231.
34. Leboulleux S, Rubino C, Baudin E, Cailou B, Hartl DM, et al. (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90: 5723-5729.
35. Yamashita H, Noguchi S, Murakami N, Toda M, Uchino S, et al. (1999) Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 86: 842-849.
36. Asanuma K, Kusama R, Maruyama M, Fujimori M, Amano J (2001) Macroscopic extranodal invasion is a risk factor for tumor recurrence in papillary thyroid cancer. Cancer Lett 164: 85-89.
37. Ito Y, Hirokawa M, Jikuzono T, Higashiyama T, Takamura Y, et al. (2007) Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 31: 1194-1201.